We herein reported that frequent PD-L1 expression was detected in VSCC tumors and tumor-infiltrating immune cells (TPS ≥ 1% in 59.4% and CPS ≥ 1 in 82.6% of the current cohort). Here, CD274 is linked to neoplasm.